493 related articles for article (PubMed ID: 23246623)
1. The novel β3-adrenoceptor agonist mirabegron reduces carbachol-induced contractile activity in detrusor tissue from patients with bladder outflow obstruction with or without detrusor overactivity.
Svalø J; Nordling J; Bouchelouche K; Andersson KE; Korstanje C; Bouchelouche P
Eur J Pharmacol; 2013 Jan; 699(1-3):101-5. PubMed ID: 23246623
[TBL] [Abstract][Full Text] [Related]
2. Modulation of non-voiding activity by the muscarinergic antagonist tolterodine and the β(3)-adrenoceptor agonist mirabegron in conscious rats with partial outflow obstruction.
Gillespie JI; Palea S; Guilloteau V; Guerard M; Lluel P; Korstanje C
BJU Int; 2012 Jul; 110(2 Pt 2):E132-42. PubMed ID: 22734512
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of a β3-adrenoceptor agonist on bladder function in a rat model of chronic bladder ischemia.
Sawada N; Nomiya M; Hood B; Koslov D; Zarifpour M; Andersson KE
Eur Urol; 2013 Oct; 64(4):664-71. PubMed ID: 23838637
[TBL] [Abstract][Full Text] [Related]
4. Long-term treatment with the beta-3 adrenoceptor agonist, mirabegron ameliorates detrusor overactivity and restores cyclic adenosine monophosphate (cAMP) levels in obese mice.
Calmasini FB; de Oliveira MG; Alexandre EC; da Silva FH; da Silva CPV; Candido TZ; Antunes E; Mónica FZ
Neurourol Urodyn; 2017 Aug; 36(6):1511-1518. PubMed ID: 27794199
[TBL] [Abstract][Full Text] [Related]
5. Urodynamics and safety of the β₃-adrenoceptor agonist mirabegron in males with lower urinary tract symptoms and bladder outlet obstruction.
Nitti VW; Rosenberg S; Mitcheson DH; He W; Fakhoury A; Martin NE
J Urol; 2013 Oct; 190(4):1320-7. PubMed ID: 23727415
[TBL] [Abstract][Full Text] [Related]
6. Mirabegron induces relaxant effects via cAMP signaling-dependent and -independent pathways in detrusor smooth muscle.
Maki T; Kajioka S; Itsumi M; Kareman E; Lee K; Shiota M; Eto M
Low Urin Tract Symptoms; 2019 Apr; 11(2):O209-O217. PubMed ID: 30632283
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo pharmacological profile of the selective β3-adrenoceptor agonist mirabegron in rats.
Hatanaka T; Ukai M; Watanabe M; Someya A; Ohtake A; Suzuki M; Ueshima K; Sato S; Sasamata M
Naunyn Schmiedebergs Arch Pharmacol; 2013 Mar; 386(3):247-53. PubMed ID: 23239087
[TBL] [Abstract][Full Text] [Related]
8. Involvement of β3-adrenoceptors in the inhibitory control of cholinergic activity in human bladder: Direct evidence by [(3)H]-acetylcholine release experiments in the isolated detrusor.
D' Agostino G; Maria Condino A; Calvi P
Eur J Pharmacol; 2015 Jul; 758():115-22. PubMed ID: 25861936
[TBL] [Abstract][Full Text] [Related]
9. Do β-adrenoceptor agonists induce homologous or heterologous desensitization in rat urinary bladder?
Michel MC
Naunyn Schmiedebergs Arch Pharmacol; 2014 Mar; 387(3):215-24. PubMed ID: 24213882
[TBL] [Abstract][Full Text] [Related]
10. Relaxant and contractile responses of detrusor muscle strips obtained from bladder outlet-obstructed rats treated with doxazosin enantiomers.
Wang M; Ren XJ; Zhao QH; Lin LX; Wang X; Zhao Y; Ren LM
Can J Physiol Pharmacol; 2011 Dec; 89(12):883-90. PubMed ID: 22115277
[TBL] [Abstract][Full Text] [Related]
11. Beta adrenergic modulation of spontaneous microcontractions and electrical field-stimulated contractions in isolated strips of rat urinary bladder from normal animals and animals with partial bladder outflow obstruction.
Gillespie JI; Rouget C; Palea S; Granato C; Korstanje C
Naunyn Schmiedebergs Arch Pharmacol; 2015 Jul; 388(7):719-26. PubMed ID: 26047780
[TBL] [Abstract][Full Text] [Related]
12. The actions of isoprenaline and mirabegron in the isolated whole rat and guinea pig bladder.
Persyn S; De Wachter S; Wyndaele JJ; Eastham J; Gillespie J
Auton Neurosci; 2016 Jul; 198():19-27. PubMed ID: 27260964
[TBL] [Abstract][Full Text] [Related]
13. Combined treatment with a β
Imamura T; Ogawa T; Minagawa T; Nagai T; Suzuki T; Saito T; Yokoyama H; Nakazawa M; Ishizuka O
Neurourol Urodyn; 2017 Apr; 36(4):1026-1033. PubMed ID: 27367573
[TBL] [Abstract][Full Text] [Related]
14. Effect of (R)-2-(2-aminothiazol-4-yl)-4'-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl} acetanilide (YM178), a novel selective beta3-adrenoceptor agonist, on bladder function.
Takasu T; Ukai M; Sato S; Matsui T; Nagase I; Maruyama T; Sasamata M; Miyata K; Uchida H; Yamaguchi O
J Pharmacol Exp Ther; 2007 May; 321(2):642-7. PubMed ID: 17293563
[TBL] [Abstract][Full Text] [Related]
15. Selective β₃-adrenoceptor agonists for the treatment of overactive bladder.
Andersson KE; Martin N; Nitti V
J Urol; 2013 Oct; 190(4):1173-80. PubMed ID: 23458471
[TBL] [Abstract][Full Text] [Related]
16. β3-Adrenoceptor-mediated relaxation of rat and human urinary bladder: roles of BKCa channels and Rho kinase.
Cernecka H; Kersten K; Maarsingh H; Elzinga CR; de Jong IJ; Korstanje C; Michel MC; Schmidt M
Naunyn Schmiedebergs Arch Pharmacol; 2015 Jul; 388(7):749-59. PubMed ID: 25956403
[TBL] [Abstract][Full Text] [Related]
17. Mirabegron, a β₃-adrenoceptor agonist for the potential treatment of urinary frequency, urinary incontinence or urgency associated with overactive bladder.
Tyagi P; Tyagi V
IDrugs; 2010 Oct; 13(10):713-22. PubMed ID: 20878594
[TBL] [Abstract][Full Text] [Related]
18. An aryloxypropanolamine hβ3-adrenoceptor agonist as bladder smooth muscle relaxant.
Tasler S; Baumgartner R; Behr-Roussel D; Oger-Roussel S; Gorny D; Giuliano F; Ney P
Eur J Pharm Sci; 2012 Aug; 46(5):381-7. PubMed ID: 22430195
[TBL] [Abstract][Full Text] [Related]
19. Possible Involvement of Muscarinic Receptor Blockade in Mirabegron Therapy for Patients with Overactive Bladder.
Yamada S; Chimoto J; Shiho M; Okura T; Morikawa K; Wakuda H; Shinozuka K
J Pharmacol Exp Ther; 2021 May; 377(2):201-206. PubMed ID: 33658313
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological effect of TRK-380, a novel selective human β3-adrenoceptor agonist, on mammalian detrusor strips.
Kanie S; Otsuka A; Yoshikawa S; Morimoto T; Hareyama N; Okazaki S; Kobayashi R; Hasebe K; Nakao K; Hayashi R; Mochizuki H; Matsumoto R; Ozono S
Urology; 2012 Mar; 79(3):744.e1-7. PubMed ID: 22197203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
